Article Text

Download PDFPDF

Myocardial hibernation and stunning: from physiological principles to clinical practice
  1. S R Redwooda,
  2. R Ferrarib,
  3. M S Marbera
  1. aDepartment of Cardiology, St Thomas’ Hospital, London, UK, bCattedra di Cardiologia, Universitá degli Studi di Brescia, Brescia, Italy
  1. Dr Michael S Marber, The Rayne Institute, Department of Cardiology, St Thomas’ Hospital, Lambeth Palace Road, London SE1 7EH, UK.

Statistics from Altmetric.com

In patients with coronary artery disease, one of the most powerful determinants of prognosis is left ventricular function.1 2 Thus, if we assume that the prognostic benefit of revascularisation is mediated through an effect on left ventricular function, two mechanisms might explain this benefit. First, coronary artery bypass surgery or angioplasty could reduce the impact of coronary artery disease on the attrition of left ventricular function—in other words, left ventricular function deteriorates more slowly following revascularisation. Second, revascularisation could improve left ventricular function per se; this mechanism assumes that there must be areas of the heart that are alive but not contracting properly, and that revascularisation will improve this contractile dysfunction. Thus impairment of left ventricular function does not necessarily mean that the myocardium is dead, but rather that it may be alive though with reduced function. This has stimulated much research into the mechanisms of reversible left ventricular dysfunction and how best to identify it.

Traditionally, presurgical investigation of patients with ischaemic heart disease has involved an exercise test and coronary angiography, and so concentrates on the first mechanism while largely ignoring the concept of reversible left ventricular dysfunction, despite its documented potential importance.3 In unselected patients with left ventricular dysfunction (ejection fraction less than 30%) undergoing surgical revascularisation, ejection fraction at six months can improve by up to 50%.3 In patients with an ejection fraction of less than 40%, the presence of a mismatch between perfusion and viability predicted improvement in heart failure after revascularisation; furthermore, in patients treated medically, the presence of mismatch was associated with worse survival than in those without mismatch but with a similar initial ejection fraction.4

Thus the identification of these patients may be of clinical importance and, if so, requires some understanding of the physiological processes underlying reversible …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.